Unblinding in the lecanemab trial in Alzheimer’s disease

Abstract

Journal Article Unblinding in the lecanemab trial in Alzheimer's disease Get access Willem A Van Gool Willem A Van Gool Department of Public and Occupational Health, Amsterdam University Medical Centre, Amsterdam, The Netherlands Correspondence to: Willem A. Van Gool Amsterdam UMC Locatie AMC—Public and Occupational Health, Meibergdreef 9 Amsterdam 1105 AZ, The Netherlands E-mail: [email protected] Search for other works by this author on: Oxford Academic PubMed Google Scholar Brain, Volume 146, Issue 11, November 2023, Page e100, https://doi.org/10.1093/brain/awad171 Published: 18 May 2023 Article history Received: 24 April 2023 Accepted: 13 May 2023 Published: 18 May 2023 Corrected and typeset: 23 August 2023

Topics & Concepts